Connor Clark & Lunn Investment Management Ltd. purchased a new position in Envista Holdings Co. (NYSE:NVST – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 30,865 shares of the company’s stock, valued at approximately $1,262,000.
Other institutional investors also recently added to or reduced their stakes in the company. Fifth Third Bancorp increased its stake in Envista by 225.8% in the 1st quarter. Fifth Third Bancorp now owns 834 shares of the company’s stock worth $34,000 after buying an additional 578 shares during the period. Eagle Bay Advisors LLC purchased a new position in Envista during the 2nd quarter valued at about $35,000. IFP Advisors Inc increased its position in Envista by 705.4% during the 1st quarter. IFP Advisors Inc now owns 1,047 shares of the company’s stock valued at $29,000 after purchasing an additional 917 shares during the period. Covestor Ltd increased its position in Envista by 35.0% during the 1st quarter. Covestor Ltd now owns 1,273 shares of the company’s stock valued at $62,000 after purchasing an additional 330 shares during the period. Finally, Parkside Financial Bank & Trust increased its position in Envista by 32.7% during the 1st quarter. Parkside Financial Bank & Trust now owns 2,481 shares of the company’s stock valued at $121,000 after purchasing an additional 612 shares during the period.
Envista Stock Down 1.9 %
Shares of Envista stock opened at $32.46 on Wednesday. The firm’s 50 day moving average price is $33.91 and its 200-day moving average price is $35.99. The company has a quick ratio of 1.04, a current ratio of 1.29 and a debt-to-equity ratio of 0.20. Envista Holdings Co. has a 52-week low of $31.20 and a 52-week high of $43.29. The company has a market cap of $5.32 billion, a P/E ratio of 26.39, a PEG ratio of 1.90 and a beta of 1.41.
Analysts Set New Price Targets
A number of research firms have commented on NVST. Bank of America cut their target price on shares of Envista from $47.00 to $45.00 in a research report on Tuesday, July 11th. TheStreet downgraded shares of Envista from a “b” rating to a “c+” rating in a research report on Friday, June 9th. One investment analyst has rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $45.50.
Envista Profile
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Featured Articles
- Five stocks we like better than Envista
- Investing in Travel Stocks Benefits
- 5 Best Fintech Banks to Invest in Now
- The 3 Best Fintech Stocks to Buy Now
- 3 Smart AI ETFs For Intelligent Passive Investing Needs
- What is an Earnings Surprise?
- 4 Reasons Zoom Video is Ready to Rock Into a Reversal
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
